期刊文献+

格列喹酮固体分散体的制备及溶出度测定 被引量:2

Preparation and Dissolution Rate of Gliquidone Solid Dispersion
原文传递
导出
摘要 目的:制备格列喹酮固体分散体并考察其体外溶出性。方法:以聚乙烯吡咯烷酮K30(PVP)、聚乙二醇6000(PEG)为载体,溶剂熔融法和溶剂法制备格列喹酮固体分散体,并与原料药比较体外溶出度。结果:载体比例越大,药物溶出愈快。载体为PVP所制固体分散体的体外溶出行为总体优于载体为PEG者。格列喹酮-PVP固体分散体(1∶7)10min内体外溶出度达到70%以上,优于格列喹酮原料药。结论:成功制备了格列喹酮固体分散体。 OBJECTIVE: To prepare gliquidone solid dispersion and to investigate its dissolution rate. METHODS: The gliquidone solid dispersion was prepared by dissolvent - fusion method and dissolvent method with PEG - 6000(PEG) and PVP K30(PVP) as carriers. RESULTS: The results of in vitro dissolubility test showed that the higher the carrier ratio, the faster the drug dissolution. The in vitro dissolubility of solid dispersions was faster with PVP than with PEG as carrier. The dissolution rate of the gliquidone- PVP (1 : 7) solid dispersion reached as high as above 70% in 10 minutes, which was superior to that of its bulk drug. CONCLUSION: The gliquidone solid dispersion has been prepared successfully.
出处 《中国药房》 CAS CSCD 北大核心 2007年第25期1955-1957,共3页 China Pharmacy
关键词 格列喹酮 固体分散体 溶出速率 聚乙二醇 聚乙烯吡咯烷酮 Gliquidone Solid dispersion Dissolution rate PEG PVP
  • 相关文献

参考文献3

  • 1Von Nicolai H,Brickl R,Eschey H,et al.Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-depen-dent(type 2) diabetes mellitus[J].Arzneimittelforschung,1997,47(3):247.
  • 2贺娟,陈勇川,戴青,夏培元.格列喹酮片人体药动学及生物等效性研究[J].中国药房,2006,17(17):1318-1320. 被引量:7
  • 3国家药典委员会编.中国药典[S].北京:化学工业出版社,2005年版二部:674.

二级参考文献5

共引文献37

同被引文献30

  • 1王宁,陈锋杰,赵语,韩璞.不同厂家尼莫地平片溶出度考察[J].中国药房,2004,15(8):501-502. 被引量:3
  • 2陈鹰,陈松,覃贝,王瑞华,李高.固体分散体技术改善长春西汀溶出特性的研究[J].广东药学院学报,2007,23(3):259-262. 被引量:3
  • 3Saito M, Uqajin T, Nozawa Y, et al. Preparation and dissolution characteristics of griseofulvin solid dispersions with saccharides[J ]. Int J Phar, 2002,249( 1-- 2) : 71.
  • 4陆彬主编.药物新剂型与新制剂[M].北京:人民卫生出版社,1998:1-23.
  • 5Gines JM, Arias MJ, Moyano JR, et al. Thermal investigation of crystallization of poly(ethylene glycol) s in solid dispersions containing oxazepam[J]. Int J Pharm , 1996, 143(11) :247.
  • 6McGinity JW, Maincent P, Steinfink H. Crystallinity and dissolution rata of tolbutamide solid dispersion prepared by the melt method[J ] .J Pharm Sci, 1984, 73 (10) : 1 441.
  • 7Ozeki T, Yuasa H, Kanaya Y. Mechanism of medicine release from solid dispersion composed of Poly(ethylene oxide) - carboxyvinylpolymer interpolymer complex and pH effcct on medicine release[J]. Int J Pharm, 1998, 171(1) : 123.
  • 8Ozeki T, Yuasa H, Kanaya Y .Control of medicine releasefrom solid dispersion composed of the poly(ethylene oxide) - carboxyvinylpolymer interpolymercomplex by varying molecular weight of poly(ethylene oxide)[J].J Controlled Release, 1999,58(1) : 87.
  • 9Ozeki T, Yuasa H, Kanaya Y. Controlled release from solid dispersion composed of poly(ethylene oxide) - Carbopol ^ interpolymer complex with variouscross- linking degrees of Carbopoly^ [J ] .J Controlled Release, 2000, 63(3) :287.
  • 10Zhu J, Yang ZG, Chen XM, et al .Preparation and physicochemical characterization of solid dispesion of quercetin and polyvinylpyr rolidone[J ] .Journal of Chinese Pharmaceutical Sciences, 2007,42(16) : 51.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部